1
CytoSorbandrhabdomyolysisandkidneyfailure
FilippoAucella,M.D.Dept.ofNephrologyandDialysis,ResearchHospital“CasaSollievodellaSofferenza”
SanGiovanniRotondoITALYCertifiedISO9001:2008
Destructionordisintegrationofstriatedmusclecellsresultingintheleakageoftheintracellularmuscleconstituentsintocirculationand
extracellularfluid.
• Creatinekinase(CK)
• Myoglobin
• Potassium,Phosphorus
• Transaminase
• LDH
BoschXetal.Rhabdomyolysisandacutekidneyinjury.NEnglJMed2009;361:62-72 2
Rhabdomyolysis: definition Huerta-AladinAL.CriticalCare2005,9:158-169
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Myoglobin
3
! MyoglobinisadarkredcytoplasmichemoproteinthatbindOxygenonahemegroup
! HighaffinityforOxygen
! 17.800Da
! PhysiologicalPlasmaLevels:0-0,003mg/dl
Pathogenicfactorinrhabdomyolysis-inducedAKI
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Rhabdomyolysis: Pathophysiology
5
Huerta-AladinAL.CriticalCare2005,9:158-169;Chavezetal.CriticalCare(2016)20:135
Myocytedestruction
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Complicationsofrhabdomyolysis
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
TheOchsnerJournal15:58–69,2015
Rhabdomyolysis and AKI
7
AcuteKidneyInjury
! Among10-50%ofpatientswithrhabdomyolysisdevelopAKI
Huerta-AladinAL.CriticalCare2005,9:158-169
! AKIassociatedwithmyoglobinuriaisthemostseriouscomplicationofrhabdomyolysis
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
PathophysiologicalMechanismsinRhabdomyolysis-Induced
AcuteKidneyInjury
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
" Renalvasocostrictionthroughhypovolemiaandactivationofcytokinecascade
" Tubularobstructionthroughtheproductionofpigmentedcasts
" Directtoxicityofmyoglobin
Focus:Preservetherenalfunction
10
" Dialysistechniqueshaveshownpoorefficacyintheremovalofcirculatingmyoglobin.
" Strategiesarerequiredfortherapidremovalofcirculatingmyoglobinandothermuscleenzymesfromtheblood.
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
• Plasmaexchange• Intermittenthemodialysis• Conventionalhemodialysis
Unfortunately,thesetherapieshavelimitedsuccessinmyoglobinremoval
Extracorporeal Therapies
" Itisimportanttopreventfurtherdamagesbyreducingthecirculatingmyoglobin
RoncoC.CriticalCare.2005;9(2):141-142.
Huerta-AladinAL.CriticalCare2005,9:158-169
• Continuosveno-venoushemofiltrationorhemodiafiltrationwiththeuseofsuperhighfluxfiltersandhighvolumesofhemofiltration
Noevidenceandtheeffectonoutcomesisunknown
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
12Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
13
mortalityandadverseeventsdidnotdiffersignificantlyamongpatientstreatedwithCRRTandconventionaltherapy
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
14Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Newsolutions:WhyAdsorption?
Adsorption:fromtheLatinadsorbere,isachemical-physicalphenomenon
thatconsistsintheaccumulationofoneormorefluidorgaseousmoleculesonthesurfaceofacondensate.
Themoleculesestablishachemical-physicalinteractionbetweenthemontheseparationsurfacebetweentwodifferent
phases
Basedonhydrophobicinteractions:Thehydrophobicinteractionsare,liketheintermolecularforcesthatholdpolarmoleculestogether,electrostaticforces.They
canbeclassifiedintwotypes:hydrophobicinteractionsthatareestablishedonlyforthe
simplereasonthattheapolarmolecules,toavoidcontactwithwater,"fallback"onthemselves
vanderWaalsforces,electrostaticforcesbetweentemporaryandinduceddipoles
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
16
0 kDa 10 20 30 40 50 60 70
TNF-α Trimer
IFN-γ dimer
IL-6 sFas Ligand
MCP-1 (Glycosylated) Albumin
IL-8 MIP-1α
IL-18
sTNFR
G-CSF IL-4
Free Hemoglobin
Myoglobin Bilirubin
Hemodialysis
HMGB1 TGF-β
CytoSorb®
MCP-1 IL-13 IL-10
IL-1a TNF-α Monomer IFN-γ Monomer
IL-1Ra
Hydrophobicmoleculesupto55-60kDa
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Performance
2mqvs40.000mqX6
In vitro evidence
Saline
Siero
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
UseofCytosorbinapatientwithipermyoglobinemiafollowingacuteischemiaoftherightlowerlimb
• 68-year-oldFemale
• Mitralvalvereplacementinminitoracotomy
• Acuteischemiaoftherightlowerlimb
• DayPO5:myoglobinemia>20.000ng/ml,CPK=7648U/l
# Surgicalresolutionofischemiaproblem
# StartCVVHDF(Qb:150ml/min;Quf:100ml/h,
Qd:1500ml/h,WL:100ml/h)+Cytosorbfor4days
18
" StabilizationofMyoglobinandCPKlevels" RenalFunctionImprovement" Normaldiuresisachieved
Cytosorb
FrancescoGreco,MatteoMelchionda,FrancescoDistaso,MinervaMedicaVol.108,Suppl2,Aprile2017
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
• 35-y-oMale
• Politraumaaftercocaineintoxication:multiplefractures,rhabdomyolysisandacutekidneyinjury
• T0:Myoglobin:>63.000ng/ml;CPK:>54.000U/L,Creatinine:2,87mg/dl
• CVVHD+Cytosorbfor48h
• After48h:Myoglobin:11.570ng/ml;CPK:6.586U/L
19
T0>63.000ng/ml
T48>11.570ng/ml
" StabilizationofMyoglobinandCPKlevels" RenalFunctionImprovement" Normaldiuresisachievedafter6days
ArboP,CarraroM,BiancoF,DimasoV,GeriniU,BerlotG,BoscuttiG.MinervaMedicaVol.108,Suppl2,Aprile2017
UseofCytosorbinapatientwithAKIassociatedtorhabdomyolysis
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Caseseries:3malepatientswithcrushsyndromeofdifferentseverityaftercentralItalyhearthquake(Averagetimeunderrubbles:9hours):# HighHematocritandhemoglobyn# Hyperkaliemia# Creatininemia# Myoglobin>12.000ng/ml:Technicallimitoftheinstrumentsinthefirstdays# IncreaseofLDH,GPT,GOT# Anuria
Patient1 Patient2 Patient3
Hemoglobyn(g/dl) 16,9 18,8 18,4Hematocrit(%) 51 55,9 56Myoglobin(ng/ml) >12.000 >12.000 >12.000CK(U/l) 14.500 300.390 156.920LDH(U/l) 883 - 8.615Potassium(mmol/l) 6,14 6,14 6,7Creatinine(mg/dl) 1,22 1,18 2,21
20
ParametersattheadmissioninER
" StandardtreatmentforRhabdomyolysis
" CRRTwithhighcut-offfilterinthefirst4days
NewtreatmentinRhabdomyolysiswithAKIinpatientswithcrushsyndromeafterhearthquakeinItaly
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Results
CRRT+HCOfiltersNondetectableMyoglobinlevels>12.000ng/ml
! Day0-4:CRRTwithhighcutofffilters:noevidenceofsignificantmyoglobinrapidreduction
! Day4:StartofCytosorb(average:3daysoftreatment)
" RapidReductionofboth,MyoglobinandCPK
" RenalFunctionRecovery" NormalDiuresisRecovery
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
• 34y-omale,bodybuilder
# StandfordtypeAaorticdissection,massiveARandcardiactamponade.• CPBtime612min,Xclamp340minutes• Aorticarchreplacementandsovra-aorticvesselsreimplantation
# SeverebiventricularfailureduringCPBweaning:peripheralV-AECMO
OnICUadmission:
# Lactate20# HR110/min,MAP62mmHg,Norepinephrine0.6mcg/kg/min,
Epinephrine0.085mcg/kg/min,Levosimendan0.05
# Anuria:CVVHDFstartedinPOD1# Hyperkalemia(7,3mM/L)andpeakofmyoglobin860.000ng/ml
andCPK511.000UI/L
# Bilirubintot2.87,AST121022
! Hemodynamicinstability
! LiverDysfunction! Rhabdomyolysis! MOF
Cytosorbafter5days
ExperienceofAziendaSanitariaUniversitariaIntegrata-Udine
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
Experience of Azienda Sanitaria Universitaria Integrata - Udine
23
T024h48h72h96h5d6d7dUI/L0
100000
200000
300000
400000
500000
600000
700000 CPK
ng/mL T024h48h72h96h5d6d0
100000
200000
300000
400000
500000
600000
700000
800000
900000
1000000 Myoglobin
" Reductionofboth,MyoglobinandCPK,toprotectkidney
" Reductionofvasopressors(Norepinephrine/Epinephrine)
CPB
mcg/kg/min
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
T024h36h
Norepinephrine
Epineprhine
Vasopressors
Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo
CytosorbInRhabdomyolisis:clinicalexperiencesInstitution ClinicalCondition N°Treatments/
totaldurationMYBInitialValue
MYBFinalValue
OtherData
UniversityofVienna
Legionella-PneumoniaAssociated
Rhabdomyolysis
2treatments/24h
18.390ng/dl 8.352ng/dl- CytosorbinHP- RenalFunction
Improvement
UniversityofLubeck
SepticShockassociatedRhabdomyolisis
4treatments/80h
30.000ug/L <1000ug/L- IL6reductionandinflammatorystateimprovement
PoliclinicoSanMarco,Zingonia
RhabdomyolisiswithARFafterlaparoscopicsleevegastrectomy
1treatment/24h 52.800ng/dl 8.862ng/dl- CPKReduction(52%)- RenalFunctionImprovement
VillaSofia,Palermo
TraumaAssociatedRhabodmyolisis–Case
series1treatment/24h
averagevalue>10.000ng/
ml
Averagereduction:58
%
- CytosorbinHP-ARFprevention,noneedforCRRT
BaggiovaraHospital,Modena
MassiveRhabdomyolisisdueto
cocaineoverdose
3treatments/63h
198.175ng/ml
36.025ng/ml- Diuresisprogressive
recovery
CattinaraHospital,Trieste
MassiveRhabdomyolisisdueto
cocaineoverdose2treatments/48h
>63.000ng/ml
11.570ng/ml- CKReduction- RenalfunctionRecovery
ChietiHospital,Chieti
CrushinducedRhabdomyolisis
2treatments/48h
>20.000ng/ml
1.480ng/mlStabilizationofallparameters
RietiHospital,Rieti
CrushinducedRhabdomyolisis
OnAverage3treatments
>12.000ng/ml
physiologicalvalues
Diuresisandrenalindicesrecovery
RhabdomyolysisinducedAKIandCytosorb
• Acute renal failure is a common complication in rhabdomyolysis, due to themyoglobinnephrotoxicity,andmayleadtoirreversiblerenaldamage;
• It is necessary to identify a proper and effective purification strategy for theremovalofthenephrotoxicmoleculescirculatingintheblood;
• Adsorptionmaybethebesttechniquetoovercomethelimitsofdialysis;
• HemoadsorptionwithCytosorbisaneffectiveandrapidmethodfortheremovalofmyoglobinandothermuscleenzymes;
• The PROJECT NATURE Study is investigating the possibility to improve thetraditionaldialytic efficiency in the reductionofuremicproteinbound toxinsbyhemoadsorbtion.
25Ospedale“CasaSollievodellaSofferenza”,IRCCS,SanGiovanniRotondo